How the Food and Drug Administration messes up approval of new drugs including the new one, aducanumab, that supposedly helps Alzheimer’s disease patients.
Getting patent waivers is essential and so is making the vaccine manufacturers share their expertise with generic companies.
Poorly paid direct care workers with multiple jobs who can’t afford sick leave spread the pandemic to the most vulnerable. Here’s how we can do better.
The shots are saving lives, but we don’t know their long-term effects thanks to an agency that often answers to industry instead of the public.
Our economy and health depends on getting poorer countries access to vaccines. Fortunately, there are ways to do that. Here’s how.